Download
bioengineering-06-00082.pdf 1,99MB
WeightNameValue
1000 Titel
  • Recent Advances in the Use of Polyhydroyalkanoates in Biomedicine
1000 Autor/in
  1. Rodriguez-Contreras, Alejandra |
1000 Erscheinungsjahr 2019
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2019-09-12
1000 Erschienen in
1000 Quellenangabe
  • 6(3):82
1000 Copyrightjahr
  • 2019
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3390/bioengineering6030082 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Polyhydroxyalkanoates (PHAs), a family of natural biopolyesters, are widely used in many applications, especially in biomedicine. Since they are produced by a variety of microorganisms, they possess special properties that synthetic polyesters do not have. Their biocompatibility, biodegradability, and non-toxicity are the crucial properties that make these biologically produced thermoplastics and elastomers suitable for their applications as biomaterials. Bacterial or archaeal fermentation by the combination of different carbohydrates or by the addition of specific inductors allows the bioproduction of a great variety of members from the PHAs family with diverse material properties. Poly(3-hydroxybutyrate) (PHB) and its copolymers, such as poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHVB) or poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (PHB4HB), are the most frequently used PHAs in the field of biomedicine. PHAs have been used in implantology as sutures and valves, in tissue engineering as bone graft substitutes, cartilage, stents for nerve repair, and cardiovascular patches. Due to their good biodegradability in the body and their breakdown products being unhazardous, they have also been remarkably applied as drug carriers for delivery systems. As lately there has been considerable and growing interest in the use of PHAs as biomaterials and their application in the field of medicine, this review provides an insight into the most recent scientific studies and advances in PHAs exploitation in biomedicine.
1000 Sacherschließung
lokal delivery system
lokal Poly(3-hydroxybutyrate)
lokal polyhydroxyalkanoates
lokal biomaterials
lokal poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHVB)
lokal biomedicine
lokal poly(3-hydroxybutyrate-co-4-hydroxybutyrate)
lokal tissue engineering
lokal wound healing
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/Um9kcmlndWV6LUNvbnRyZXJhcywgQWxlamFuZHJh
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
  1. Recent Advances in the Use of Polyhydroyalkanoates in Biomedicine
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6420085.rdf
1000 Erstellt am 2020-04-15T12:05:55.284+0200
1000 Erstellt von 21
1000 beschreibt frl:6420085
1000 Bearbeitet von 21
1000 Zuletzt bearbeitet 2020-04-15T12:21:25.339+0200
1000 Objekt bearb. Wed Apr 15 12:21:14 CEST 2020
1000 Vgl. frl:6420085
1000 Oai Id
  1. oai:frl.publisso.de:frl:6420085 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source